Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can bifocals plus eye drops beat drops alone for Kids' nearsightedness?

NCT ID NCT07614113

Disease control Sponsor: University of Faisalabad Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether adding bifocal glasses to daily atropine eye drops works better than atropine alone to slow down nearsightedness (myopia) in children. 210 kids aged 4-16 with worsening myopia took part. The main goal was to measure changes in their vision prescription and eye length over one year.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

210 people

The number who actually took part.

Started

Feb 2025

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

4 to 16 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children aged 4 to 16 years * Bilateral myopia with cycloplegic spherical equivalent refraction between -1.00 D and -6.00 D in each eye * Documented recent myopia progression of ≥ -0.50 D over the preceding 12 months * Best-corrected visual acuity (BCVA) of at least 6/12 (Snellen) or equivalent in each eye * Parent or guardian able and willing to provide written informed consent * Child assent when applicable (age 7 years and above per institutional policy) Exclusion Criteria: * Ocular conditions affecting myopia progression: strabismus, amblyopia, significant astigmatism (\>2.50 D), anisometropia (\>2.50 D), cataract, glaucoma, uveitis, or history of ocular surgery * Prior myopia-control treatment within 6 months (atropine, orthokeratology, multifocal contact lenses, pirenzepine) * Known allergy or hypersensitivity to atropine or spectacle materials * Systemic or neurodevelopmental disorders affecting cooperation or refractive development * Inability to obtain accurate axial length or cycloplegic refraction measurements * Parent or guardian refusal to provide informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Myopia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

degenerative myopia myopia refractive error

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Myopia Progressive myopia Refractive errors

Contacts and locations

Locations

  • The University of Faisalabad

    Faisalābad, Punjab Province, 3800, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.